PDB Short entry for 2AB2 HEADER TRANSCRIPTION 14-JUL-05 2AB2 TITLE MINERALOCORTICOID RECEPTOR DOUBLE MUTANT WITH BOUND SPIRONOLACTONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MR LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: MR; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS GST KEYWDS MINERALOCORTICOID RECEPTOR, MR, NUCLEAR RECEPTOR, STEROID RECEPTOR, KEYWDS 2 SPIRONOLACTONE, HYPERTENSION, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO,M.H.LAMBERT,K.H.PEARCE, AUTHOR 2 T.B.STANLEY,E.L.STEWART,R.P.TRUMP,T.M.WILLSON,S.P.WILLIAMS REVDAT 6 14-FEB-24 2AB2 1 REMARK REVDAT 5 20-OCT-21 2AB2 1 REMARK SEQADV HETSYN REVDAT 4 11-OCT-17 2AB2 1 REMARK REVDAT 3 24-FEB-09 2AB2 1 VERSN REVDAT 2 13-SEP-05 2AB2 1 JRNL REVDAT 1 26-JUL-05 2AB2 0 JRNL AUTH R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO,M.H.LAMBERT, JRNL AUTH 2 K.H.PEARCE,T.B.STANLEY,E.L.STEWART,R.P.TRUMP,T.M.WILLSON, JRNL AUTH 3 S.P.WILLIAMS JRNL TITL A LIGAND-MEDIATED HYDROGEN BOND NETWORK REQUIRED FOR THE JRNL TITL 2 ACTIVATION OF THE MINERALOCORTICOID RECEPTOR JRNL REF J.BIOL.CHEM. V. 280 31283 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15967794 JRNL DOI 10.1074/JBC.M504098200 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 54688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3968 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4090 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01800 REMARK 3 B22 (A**2) : -0.02400 REMARK 3 B33 (A**2) : 0.00600 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.259 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : SCD.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AB2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033699. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54805 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.39500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: MR LBD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH7.5, 0.9M LI2SO4, 2% PEG REMARK 280 2KMME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.09700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.93800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.96950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 85.93800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.09700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.96950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL UNIT IS A REMARK 300 DIMER, BUT THE DIMER IN THE CRYSTAL IS IRRELEVANT REMARK 300 BIOLOGICALLY. THE BIOLOGICAL DIMER IS CURRENTLY UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 710 REMARK 465 SER A 711 REMARK 465 ALA A 712 REMARK 465 PRO A 713 REMARK 465 ALA A 714 REMARK 465 LYS A 715 REMARK 465 GLU A 716 REMARK 465 PRO A 717 REMARK 465 SER A 718 REMARK 465 VAL A 719 REMARK 465 ASN A 720 REMARK 465 THR A 721 REMARK 465 ALA A 722 REMARK 465 PRO A 911 REMARK 465 ARG A 983 REMARK 465 LYS A 984 REMARK 465 GLY B 710 REMARK 465 SER B 711 REMARK 465 ALA B 712 REMARK 465 PRO B 713 REMARK 465 ALA B 714 REMARK 465 LYS B 715 REMARK 465 GLU B 716 REMARK 465 PRO B 717 REMARK 465 SER B 718 REMARK 465 VAL B 719 REMARK 465 ASN B 720 REMARK 465 THR B 721 REMARK 465 ALA B 722 REMARK 465 LYS B 909 REMARK 465 ARG B 983 REMARK 465 LYS B 984 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 723 CG CD1 CD2 REMARK 470 LEU A 727 CG CD1 CD2 REMARK 470 ARG A 732 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 791 CG CD CE NZ REMARK 470 GLU A 796 CG CD OE1 OE2 REMARK 470 LYS A 820 CG CD CE NZ REMARK 470 ARG A 861 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 883 CG CD CE NZ REMARK 470 LYS A 901 CG CD CE NZ REMARK 470 LYS A 905 CG CD CE NZ REMARK 470 LYS A 909 CG CD CE NZ REMARK 470 CYS A 910 SG REMARK 470 ASN A 912 CG OD1 ND2 REMARK 470 GLN A 916 CG CD OE1 NE2 REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 LEU B 723 CG CD1 CD2 REMARK 470 LEU B 727 CG CD1 CD2 REMARK 470 ARG B 732 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 771 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 791 CG CD CE NZ REMARK 470 ASN B 792 CG OD1 ND2 REMARK 470 GLU B 796 CG CD OE1 OE2 REMARK 470 LYS B 820 CG CD CE NZ REMARK 470 ARG B 861 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 883 CG CD CE NZ REMARK 470 LYS B 901 CG CD CE NZ REMARK 470 ARG B 904 CG CD NE CZ NH1 NH2 REMARK 470 CYS B 910 SG REMARK 470 PRO B 911 CG CD REMARK 470 GLN B 916 CG CD OE1 NE2 REMARK 470 LYS B 926 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 884 -72.55 -54.26 REMARK 500 ASN A 913 75.88 -169.11 REMARK 500 PRO B 911 83.13 31.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SNL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SNL B 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AA2 RELATED DB: PDB REMARK 900 MR WITH BOUND ALDOSTERONE REMARK 900 RELATED ID: 2AA5 RELATED DB: PDB REMARK 900 MR WITH BOUND PROGESTERONE REMARK 900 RELATED ID: 2AA7 RELATED DB: PDB REMARK 900 MR WITH BOUND DEOXYCORTICOSTERONE REMARK 900 RELATED ID: 2AA6 RELATED DB: PDB REMARK 900 MR DOUBLE MUTANT WITH BOUND PROGESTERONE REMARK 900 RELATED ID: 2AAX RELATED DB: PDB REMARK 900 MR DOUBLE MUTANT WITH BOUND CORTISONE DBREF 2AB2 A 712 984 UNP P08235 MCR_HUMAN 712 984 DBREF 2AB2 B 712 984 UNP P08235 MCR_HUMAN 712 984 SEQADV 2AB2 GLY A 710 UNP P08235 CLONING ARTIFACT SEQADV 2AB2 SER A 711 UNP P08235 CLONING ARTIFACT SEQADV 2AB2 SER A 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 2AB2 LEU A 810 UNP P08235 SER 810 ENGINEERED MUTATION SEQADV 2AB2 GLY B 710 UNP P08235 CLONING ARTIFACT SEQADV 2AB2 SER B 711 UNP P08235 CLONING ARTIFACT SEQADV 2AB2 SER B 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 2AB2 LEU B 810 UNP P08235 SER 810 ENGINEERED MUTATION SEQRES 1 A 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 A 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 A 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 A 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 A 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 A 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 A 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 A 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 A 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 A 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 A 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 A 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 A 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 A 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 A 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 A 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 A 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 A 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 A 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 A 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 A 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 A 275 ARG LYS SEQRES 1 B 275 GLY SER ALA PRO ALA LYS GLU PRO SER VAL ASN THR ALA SEQRES 2 B 275 LEU VAL PRO GLN LEU SER THR ILE SER ARG ALA LEU THR SEQRES 3 B 275 PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU PRO GLU SEQRES 4 B 275 ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO ASP THR SEQRES 5 B 275 ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU ALA GLY SEQRES 6 B 275 LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS VAL LEU SEQRES 7 B 275 PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN ILE THR SEQRES 8 B 275 LEU ILE GLN TYR SER TRP MET SER LEU LEU SER PHE ALA SEQRES 9 B 275 LEU SER TRP ARG SER TYR LYS HIS THR ASN SER GLN PHE SEQRES 10 B 275 LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU GLU LYS SEQRES 11 B 275 MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN GLY MET SEQRES 12 B 275 HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN LEU THR SEQRES 13 B 275 PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU LEU LEU SEQRES 14 B 275 SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN ALA ALA SEQRES 15 B 275 PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU LEU ARG SEQRES 16 B 275 LYS MET VAL THR LYS CYS PRO ASN ASN SER GLY GLN SER SEQRES 17 B 275 TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU ASP SER SEQRES 18 B 275 MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE CYS PHE SEQRES 19 B 275 TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL GLU PHE SEQRES 20 B 275 PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN LEU PRO SEQRES 21 B 275 LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR PHE HIS SEQRES 22 B 275 ARG LYS HET SNL A 502 29 HET SO4 B 501 5 HET SNL B 503 29 HETNAM SNL SPIRONOLACTONE HETNAM SO4 SULFATE ION HETSYN SNL 17-HYDROXY-7ALPHA-MERCAPTO-3-OXO-17ALPHA-PREGN-4-ENE- HETSYN 2 SNL 21- CARBOXYLIC ACID; GAMMA-LACTONE ACETATE FORMUL 3 SNL 2(C24 H32 O4 S) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *429(H2 O) HELIX 1 1 SER A 728 THR A 735 1 8 HELIX 2 2 SER A 737 GLU A 746 1 10 HELIX 3 3 THR A 761 VAL A 786 1 26 HELIX 4 4 GLY A 789 LEU A 793 5 5 HELIX 5 5 PRO A 794 ASN A 823 1 30 HELIX 6 6 ASN A 836 SER A 843 1 8 HELIX 7 7 MET A 845 GLN A 863 1 19 HELIX 8 8 THR A 865 LEU A 878 1 14 HELIX 9 9 SER A 888 VAL A 907 1 20 HELIX 10 10 ASN A 913 GLU A 948 1 36 HELIX 11 11 GLU A 948 LYS A 953 1 6 HELIX 12 12 PRO A 957 SER A 973 1 17 HELIX 13 13 SER B 728 THR B 735 1 8 HELIX 14 14 SER B 737 GLU B 746 1 10 HELIX 15 15 THR B 761 VAL B 786 1 26 HELIX 16 16 GLY B 789 LEU B 793 5 5 HELIX 17 17 PRO B 794 ASN B 823 1 30 HELIX 18 18 ASN B 836 SER B 843 1 8 HELIX 19 19 MET B 845 GLN B 863 1 19 HELIX 20 20 THR B 865 LEU B 878 1 14 HELIX 21 21 SER B 888 VAL B 907 1 20 HELIX 22 22 ASN B 913 GLU B 948 1 36 HELIX 23 23 GLU B 948 LYS B 953 1 6 HELIX 24 24 PRO B 957 SER B 973 1 17 SHEET 1 A 2 LEU A 827 ALA A 830 0 SHEET 2 A 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 B 2 THR A 880 PRO A 882 0 SHEET 2 B 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SHEET 1 C 2 LEU B 827 ALA B 830 0 SHEET 2 C 2 LEU B 833 PHE B 835 -1 O PHE B 835 N LEU B 827 SHEET 1 D 2 THR B 880 PRO B 882 0 SHEET 2 D 2 ALA B 976 PRO B 978 -1 O LYS B 977 N ILE B 881 SITE 1 AC1 6 HOH A 102 PRO A 759 ASP A 760 SER B 756 SITE 2 AC1 6 SER B 757 LYS B 953 SITE 1 AC2 15 LEU A 766 LEU A 769 ASN A 770 ALA A 773 SITE 2 AC2 15 GLN A 776 MET A 807 LEU A 810 ARG A 817 SITE 3 AC2 15 PHE A 829 MET A 845 MET A 852 PHE A 941 SITE 4 AC2 15 CYS A 942 THR A 945 PHE A 956 SITE 1 AC3 15 LEU B 766 LEU B 769 ASN B 770 ALA B 773 SITE 2 AC3 15 GLN B 776 MET B 807 LEU B 810 ARG B 817 SITE 3 AC3 15 PHE B 829 MET B 845 MET B 852 PHE B 941 SITE 4 AC3 15 CYS B 942 THR B 945 PHE B 956 CRYST1 42.194 89.939 171.876 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023700 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011119 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005818 0.00000